3DBiopsy Company
%20.jpg)
3DBiopsy, Inc. is a medical device company that is developing a comprehensive System ultimately intended to aid in the diagnosis and treatment planning of prostate cancer—the most commonly diagnosed significant male cancer and second leading cause of cancer deaths. Created by prostate cancer specialists, the 3DBiopsy System is expected to achieve improvements in biopsy accuracy which may reduce the need for radical surgery or full radiation and lower costs for the healthcare industry.
Total Funding:
$2.2M
Headquarters:
Aurora, Colorado, United States
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Venture - Series Unknown
Technology:
P4 Medicine
Investor Type:
For Profit
Founded Date:
2012-01-01
Industry:
Health Care, Health Diagnostics, Medical Device